Triptorelin Acetate
GnRH agonist for precocious puberty and oncology treatment. Potent testosterone/estrogen suppression with sustained release formulations for long-term hormone therapy.
Triptorelin Acetate is a synthetic decapeptide agonist of gonadotropin-releasing hormone (GnRH), also known as luteinizing hormone-releasing hormone (LHRH). Structurally modified at the 6th amino acid position (D-tryptophan substitution), it exhibits significantly enhanced receptor affinity and a prolonged plasma half-life compared to native GnRH, making it one of the most potent GnRH agonists available for therapeutic use.
| Parameter | Specification |
| CAS | 57773-63-4 |
| Molecular Formula | C₆₄H₈₂N₁₈O₁₃ |
| Molecular Weight | 1311.46 g/mol |
| Category | GnRH/Reproductive |
| Purity | ≥99% |
| Status | GMP-compliant, FDA-ready |
| Applications | Precocious puberty, prostate cancer, breast cancer, fertility preservation |
| CAS | 57773-63-4 |
|---|---|
| Applications | Assisted Reproduction, Endometriosis, Precocious Puberty, Uterine Fibroids |
Related products
-
Semaglutide
CAS: 910463-68-2Applications: cardiovascular risk reduction, obesity management, Type 2 diabetes -
Exenatide Acetate
CAS: 141732-76-5Applications: GLP-1, obesity management, Type 2 diabetes -
Ganirelix
CAS: 123246-29-7 -
Apraglutide
CAS: 1295353-98-8Applications: GLP-2, Intestinal Repair, Mucosal Growth, Short Bowel Syndrome